QA: Dynavax Technologies CORP in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2023_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 916,985,000
1 IntangibleAssetsNetIncludingGoodwill 2,006,000
2 PropertyPlantAndEquipmentNet 37,596,000
3 remainder_Assets 29,263,000
4 LiabilitiesCurrent 150,074,000
5 LiabilitiesNoncurrent 33,185,000
6 remainder_Liabilities 221,578,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 134,180,920
9 ResearchAndDevelopmentExpense 47,166,557
10 remainder_Expenses 258,029,554
11 remainder_Revenues 820,138,623
12 remainder_NetIncome 9,109,219
13 remainder_ComprehensiveNetIncome -1,812,614
  yvar yval
0 Assets 985,850,000
1 Liabilities 404,837,000
2 Expenses 439,377,031
3 Revenues 820,138,623
4 StockholdersEquity 581,013,000
5 NetIncome 389,870,811
6 ComprehensiveNetIncome 388,964,504
7 BaseVar 1,330,562,244
8 EconomicCapitalRatiobeforeLimitedLiability 2.38
9 EconomicCapitalRatio 3.28

Edgar->Model Mapping

Feature Distribution

Change over Time